#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant oligodendroglioma Tourette's disorder Fragile X syndrome Human papilloma virus immunisation Rhabdomyosarcoma Amyotrophic lateral sclerosis Allogenic stem cell transplantation Ocular myasthenia Cardiac amyloidosis Acute graft versus host disease in intestine Epilepsy with myoclonic-atonic seizures Hereditary angioedema Kearns-Sayre syndrome Juvenile psoriatic arthritis Staphylococcal infection More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Haemophilia A without inhibitors – Trials in Disease MELAS syndrome – Trials in Disease Adrenocortical carcinoma – Diagnostics Haemophagocytic lymphohistiocytosis – Life with Disease Myelodysplastic syndrome – Basic Information Idiopathic pulmonary fibrosis – Diagnostics Acquired haemophilia – Life with Disease Acquired haemophilia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Choriogonadotropin Alfa Pimavanserin Tartrate Mk-0616 RO7268489 Levobupivacaine Atorvastatin Nnc0194-0499 Levodopa SEPOFARSEN Pramipexole Regn7075 IBUZATRELVIR Doxazosin Mesilate Clodronate Disodium Interferon Alfa Etrasimod Arginine Odronextamab Eptacog Beta (Activated) Abc-23B-116 Remimazolam More therapies…

    Learn about Your Condition

    Familial hypertriglyceridaemia Aneurysm ruptured Hypersomnia Lung adenocarcinoma stage IV Thrombosis prophylaxis Myeloproliferative neoplasm Subdural haematoma Facial paresis Vomiting Bone metabolism disorder Post cardiac arrest syndrome Cervical dysplasia Monogenic diabetes Breast neoplasm Diabetic foot infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effect of Post-Surgery Chemotherapy with Irinotecan and Drug Combination for Patients with Colorectal Cancer and Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Methylprednisolone
    • Irinotecan
    France

  • Study on the Effect of Genicular Arteries Embolization with Ioversol and Ethyl Esters of Iodised Fatty Acids in Patients with Symptomatic Knee Osteoarthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Ethyl Esters Of Iodised Fatty Acids From Poppyseed Oil
    • Heparin Sodium
    France

  • Study on Infliximab for Children with Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Infliximab
    The Netherlands

  • Study on the Use of Plasma Rich in Growth Factors for Treating Foot Ulcers in Diabetic Patients with Peripheral Arterial Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study of Nivolumab for Patients with Metastatic Solid Tumors and Leptomeningeal Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Metastases to meninges
    Investigated Drugs:
    • Nivolumab
    Germany

  • Study to evaluate oxygen therapy effects on physical activity in patients with fibrotic interstitial lung disease who experience low oxygen levels during exercise

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Oxygen
    Spain
Previous Page
1 … 490 491 492 493 494 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!